157 related articles for article (PubMed ID: 17094796)
1. Modification of the Tet-On regulatory system prevents the conditional-live HIV-1 variant from losing doxycycline-control.
Zhou X; Vink M; Berkhout B; Das AT
Retrovirology; 2006 Nov; 3():82. PubMed ID: 17094796
[TBL] [Abstract][Full Text] [Related]
2. Optimization of the Tet-On system for regulated gene expression through viral evolution.
Zhou X; Vink M; Klaver B; Berkhout B; Das AT
Gene Ther; 2006 Oct; 13(19):1382-90. PubMed ID: 16724096
[TBL] [Abstract][Full Text] [Related]
3. Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat.
Verhoef K; Marzio G; Hillen W; Bujard H; Berkhout B
J Virol; 2001 Jan; 75(2):979-87. PubMed ID: 11134311
[TBL] [Abstract][Full Text] [Related]
4. Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of tat in viral replication.
Das AT; Klaver B; Harwig A; Vink M; Ooms M; Centlivre M; Berkhout B
J Virol; 2007 Oct; 81(20):11159-69. PubMed ID: 17670816
[TBL] [Abstract][Full Text] [Related]
5. The genetic stability of a conditional live HIV-1 variant can be improved by mutations in the Tet-On regulatory system that restrain evolution.
Zhou X; Vink M; Klaver B; Verhoef K; Marzio G; Das AT; Berkhout B
J Biol Chem; 2006 Jun; 281(25):17084-17091. PubMed ID: 16627480
[TBL] [Abstract][Full Text] [Related]
6. Conditional virus replication as an approach to a safe live attenuated human immunodeficiency virus vaccine.
Berkhout B; Verhoef K; Marzio G; Klaver B; Vink M; Zhou X; Das AT
J Neurovirol; 2002 Dec; 8 Suppl 2():134-7. PubMed ID: 12491165
[TBL] [Abstract][Full Text] [Related]
7. Dox-dependent SIVmac with tetracycline-inducible promoter in the U3 promoter region.
Xiao Y; Kuwata T; Miura T; Hayami M; Shida H
Virology; 2000 Apr; 269(2):268-75. PubMed ID: 10753705
[TBL] [Abstract][Full Text] [Related]
8. Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolution.
Das AT; Klaver B; Centlivre M; Harwig A; Ooms M; Page M; Almond N; Yuan F; Piatak M; Lifson JD; Berkhout B
Retrovirology; 2008 Jun; 5():44. PubMed ID: 18533993
[TBL] [Abstract][Full Text] [Related]
9. In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies.
Marzio G; Verhoef K; Vink M; Berkhout B
Proc Natl Acad Sci U S A; 2001 May; 98(11):6342-7. PubMed ID: 11353837
[TBL] [Abstract][Full Text] [Related]
10. Improved single-chain transactivators of the Tet-On gene expression system.
Zhou X; Symons J; Hoppes R; Krueger C; Berens C; Hillen W; Berkhout B; Das AT
BMC Biotechnol; 2007 Jan; 7():6. PubMed ID: 17239234
[TBL] [Abstract][Full Text] [Related]
11. Improving the safety of a conditional-live human immunodeficiency virus type 1 vaccine by controlling both gene expression and cell entry.
Das AT; Baldwin CE; Vink M; Berkhout B
J Virol; 2005 Mar; 79(6):3855-8. PubMed ID: 15731280
[TBL] [Abstract][Full Text] [Related]
12. Conditionally replicating HIV and SIV variants.
Das AT; Berkhout B
Virus Res; 2016 May; 216():66-75. PubMed ID: 25982510
[TBL] [Abstract][Full Text] [Related]
13. A conditionally replicating HIV-based vector that stably expresses an antiviral shRNA against HIV-1 replication.
Westerhout EM; Vink M; Haasnoot PC; Das AT; Berkhout B
Mol Ther; 2006 Aug; 14(2):268-75. PubMed ID: 16697708
[TBL] [Abstract][Full Text] [Related]
14. A bidirectional Tet-dependent promotor construct regulating the expression of E1A for tight control of oncolytic adenovirus replication.
Fechner H; Wang X; Picó AH; Wildner J; Suckau L; Pinkert S; Sipo I; Weger S; Poller W
J Biotechnol; 2007 Jan; 127(4):560-74. PubMed ID: 17083991
[TBL] [Abstract][Full Text] [Related]
15. Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo.
Koponen JK; Kankkonen H; Kannasto J; Wirth T; Hillen W; Bujard H; Ylä-Herttuala S
Gene Ther; 2003 Mar; 10(6):459-66. PubMed ID: 12621450
[TBL] [Abstract][Full Text] [Related]
16. Inducibility of doxycycline-regulated gene in neural and neuroendocrine cells strongly depends on the appropriate choice of a tetracycline-responsive promoter.
Klopotowska D; Strzadala L; Matuszyk J
Neurochem Int; 2008 Jan; 52(1-2):221-9. PubMed ID: 17618706
[TBL] [Abstract][Full Text] [Related]
17. A conditionally replicating virus as a novel approach toward an HIV vaccine.
Das AT; Verhoef K; Berkhout B
Methods Enzymol; 2004; 388():359-79. PubMed ID: 15289083
[No Abstract] [Full Text] [Related]
18. Construction of Nef-positive doxycycline-dependent HIV-1 variants using bicistronic expression elements.
van der Velden YU; Kleibeuker W; Harwig A; Klaver B; Siteur-van Rijnstra E; Frankin E; Berkhout B; Das AT
Virology; 2016 Jan; 488():96-107. PubMed ID: 26615334
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary study on regulable DNA vaccines against Plasmodium falciparum].
Lei JC; Miao J; Li X; Schonig K; Bujard H; Xue CF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):356-9. PubMed ID: 15193238
[TBL] [Abstract][Full Text] [Related]
20. Viral evolution as a tool to improve the tetracycline-regulated gene expression system.
Das AT; Zhou X; Vink M; Klaver B; Verhoef K; Marzio G; Berkhout B
J Biol Chem; 2004 Apr; 279(18):18776-82. PubMed ID: 14761948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
